Your browser doesn't support javascript.
loading
Prefusion F-Based Polyanhydride Nanovaccine Induces Both Humoral and Cell-Mediated Immunity Resulting in Long-Lasting Protection against Respiratory Syncytial Virus.
Stephens, Laura M; Ross, Kathleen A; Waldstein, Kody A; Legge, Kevin L; McLellan, Jason S; Narasimhan, Balaji; Varga, Steven M.
Affiliation
  • Stephens LM; Interdisciplinary Graduate Program in Immunology, University of Iowa, Iowa City, IA.
  • Ross KA; Department of Chemical and Biological Engineering, Iowa State University, Ames, IA.
  • Waldstein KA; Nanovaccine Institute, Ames, IA.
  • Legge KL; Interdisciplinary Graduate Program in Immunology, University of Iowa, Iowa City, IA.
  • McLellan JS; Interdisciplinary Graduate Program in Immunology, University of Iowa, Iowa City, IA.
  • Narasimhan B; Nanovaccine Institute, Ames, IA.
  • Varga SM; Department of Microbiology and Immunology, University of Iowa, Iowa City, IA.
J Immunol ; 206(9): 2122-2134, 2021 05 01.
Article in En | MEDLINE | ID: mdl-33827894

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Respiratory Syncytial Virus, Human / Respiratory Syncytial Virus Vaccines / Polyanhydrides / Immunity, Cellular Limits: Animals Language: En Journal: J Immunol Year: 2021 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Respiratory Syncytial Virus, Human / Respiratory Syncytial Virus Vaccines / Polyanhydrides / Immunity, Cellular Limits: Animals Language: En Journal: J Immunol Year: 2021 Document type: Article Country of publication: United States